Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 11.06% is 25% below its 5-year average of 14.80%, near the low end of its 5-year range (11.06%–17.31%).
As of the fiscal period ended Tuesday, June 30, 2026. 8.99% below its 12-month average of 12.15%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation.
RETURN ON EQUITY (ROE)
11.06%
RETURN ON EQUITY (ROE) AVG TTM
12.15%
RETURN ON EQUITY (ROE) AVG 3Y
14.03%
RETURN ON EQUITY (ROE) AVG 5Y
14.80%
RETURN ON EQUITY (ROE) AVG 10Y
14.05%
RETURN ON EQUITY (ROE) AVG 15Y
13.03%
RETURN ON EQUITY (ROE) AVG 20Y
13.22%
CURRENT VS TTM AVG
-8.99%
CURRENT VS 3Y AVG
-21.19%
CURRENT VS 5Y AVG
-25.30%
CURRENT VS 10Y AVG
-21.31%
CURRENT VS 15Y AVG
-15.12%
CURRENT VS 20Y AVG
-16.34%
SECTOR MEDIAN · HEALTHCARE
13.01%
median of 84 covered companies
CURRENT VS SECTOR MEDIAN
-15.01%
vs the sector median at left
Elevance Health Inc.
Market Cap
$86.50B
Return on Equity (ROE)
11.06%
TTM Avg
12.15%
3Y Avg
14.03%
5Y Avg
14.80%
Market Cap
$83.11B
Return on Equity (ROE)
13.65%
TTM Avg
14.72%
3Y Avg
15.95%
5Y Avg
23.11%
Market Cap
$91.81B
Return on Equity (ROE)
N/A
TTM Avg
-171.53%
3Y Avg
-210.62%
5Y Avg
-155.29%
Market Cap
$72.86B
Return on Equity (ROE)
15.05%
TTM Avg
11.32%
3Y Avg
12.19%
5Y Avg
12.83%
Market Cap
$104.80B
Return on Equity (ROE)
N/A
TTM Avg
-189.06%
3Y Avg
-180.53%
5Y Avg
3473.86%
Market Cap
$67.48B
Return on Equity (ROE)
14.71%
TTM Avg
10.21%
3Y Avg
8.16%
5Y Avg
6.40%
Market Cap
$106.26B
Return on Equity (ROE)
15.55%
TTM Avg
14.50%
3Y Avg
15.05%
5Y Avg
14.30%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Elevance Health Inc. (ELV) | $86.50B | 11.06% | 12.15% | 14.03% | 14.80% |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $83.11B | 13.65% | 14.72% | 15.95% | 23.11% |
| HCA Healthcare, Inc. (HCA)vs › | $91.81B | N/A | -171.53% | -210.62% | -155.29% |
| GSK plc (GSK)vs › | $97.77B | 27.67% | 26.90% | 55.97% | 45.70% |
| Cigna Corporation (CI)vs › | $72.86B | 15.05% | 11.32% | 12.19% | 12.83% |
| Sanofi (SNY)vs › | $103.21B | 5.82% | 9.06% | 9.15% | 10.86% |
| McKesson Corporation (MCK)vs › | $104.80B | N/A | -189.06% | -180.53% | 3473.86% |
| Boston Scientific Corporation (BSX)vs › | $67.48B | 14.71% | 10.21% | 8.16% | 6.40% |
| Stryker Corporation (SYK)vs › | $106.26B | 15.55% | 14.50% | 15.05% | 14.30% |
| Cencora, Inc. (COR)vs › | $63.28B | 86.03% | 168.34% | -32.99% | 148.52% |
ROE
11.1%
ROA
3.9%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 11.06% |
| 2026-03-31 | 11.94% |
| 2025-12-31 | 12.90% |
| 2025-09-30 | 12.59% |
| 2025-06-30 | 12.26% |
| 2025-03-31 | 13.92% |
| 2024-12-31 | 14.47% |
| 2024-09-30 | 14.66% |
| 2024-06-30 | 15.86% |
| 2024-03-31 | 15.38% |
| 2023-12-31 | 15.23% |
| 2023-09-30 | 15.61% |
| 2023-06-30 | 16.52% |
| 2023-03-31 | 16.31% |
| 2022-12-31 | 16.26% |
| 2022-09-30 | 17.13% |
| 2022-06-30 | 16.96% |
| 2022-03-31 | 17.31% |
| 2021-12-31 | 16.93% |
| 2021-09-30 | 15.44% |
| 2021-06-30 | 12.10% |
| 2021-03-31 | 13.92% |
| 2020-12-31 | 13.77% |
| 2020-09-30 | 14.61% |
| 2020-06-30 | 17.17% |
| 2020-03-31 | 15.08% |
| 2019-12-31 | 15.15% |
| 2019-09-30 | 13.72% |
| 2019-06-30 | 13.23% |
| 2019-03-31 | 13.30% |
| 2018-12-31 | 13.14% |
| 2018-09-30 | 15.66% |
| 2018-06-30 | 15.12% |
| 2018-03-31 | 15.35% |
| 2017-12-31 | 14.50% |
| 2017-09-30 | 11.49% |
| 2017-06-30 | 10.79% |
| 2017-03-31 | 10.64% |
| 2016-12-31 | 9.84% |
| 2016-09-30 | 9.22% |
| 2016-06-30 | 9.57% |
| 2016-03-31 | 10.18% |
| 2015-12-31 | 11.11% |
| 2015-09-30 | 12.42% |
| 2015-06-30 | 12.41% |
| 2015-03-31 | 11.23% |
| 2014-12-31 | 10.60% |
| 2014-09-30 | 9.10% |
| 2014-06-30 | 9.17% |
| 2014-03-31 | 9.47% |
| 2013-12-31 | 10.05% |
| 2013-09-30 | 11.31% |
| 2013-06-30 | 11.58% |
| 2013-03-31 | 11.04% |
| 2012-12-31 | 11.16% |
| 2012-09-30 | 10.61% |
| 2012-06-30 | 10.65% |
| 2012-03-31 | 10.95% |
| 2011-12-31 | 11.36% |
| 2011-09-30 | 12.06% |
| 2011-06-30 | 12.06% |
| 2011-03-31 | 12.25% |
| 2010-12-31 | 12.12% |
| 2010-09-30 | 20.85% |
| 2010-06-30 | 21.32% |
| 2010-03-31 | 20.56% |
| 2009-12-31 | 19.09% |
| 2009-09-30 | 10.21% |
| 2009-06-30 | 10.90% |
| 2009-03-31 | 11.54% |
| 2008-12-31 | 11.62% |
| 2008-09-30 | 13.93% |
| 2008-06-30 | 14.42% |
| 2008-03-31 | 14.65% |
| 2007-12-31 | 14.55% |
| 2007-09-30 | 13.89% |
| 2007-06-30 | 12.93% |
| 2007-03-31 | 12.52% |
| 2006-12-31 | 12.59% |
| 2006-09-30 | 12.20% |
| 2006-06-30 | 11.94% |
| 2006-03-31 | 10.72% |
| 2005-12-31 | 9.86% |
| 2005-09-30 | 9.40% |
| 2005-06-30 | 7.77% |
| 2005-03-31 | 6.38% |
| 2004-12-31 | 4.93% |
| 2004-09-30 | 14.47% |
| 2004-06-30 | 14.30% |
| 2004-03-31 | 13.82% |
| 2003-12-31 | 12.91% |
| 2003-09-30 | 12.60% |
| 2003-06-30 | 12.42% |
